Immunic, Inc. is trading 5.9% up at $13.84, extending a sharp rebound that began earlier this week after prior weakness in the biotech and small-cap sectors.
- The move appears to be a continuation of yesterday’s strength and short-term mean reversion in the volatile micro-cap biotech stock.
- No fresh company-specific headlines or analyst calls have been reported for June 12, 2026, indicating the price action lacks a new fundamental catalyst.